Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
NCT Number: NCT03943732
The objective of this study is to measure how the use of Film-Array Pneumonia (FA-PNEU) on respiratory samples of adult patients suspected of acute care pneumonia in the intensive care unit of Saint-Luc University Hospital can accelerate / improve the initiation of the optimal antibiotic treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Brussels, 1200, Belgium
The main objective of this trial is to confirm/attest/prove the following statement:
The use of the FilmArray Pneumonia panel on respiratory samples of critically ill suspected with pneumonia, enables a faster microbiological pneumonia diagnosis and an improved therapeutic management of the patient.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Suspicion will be based on symptoms, clinical, biological and radiological criteria.
Exclusion criteria
FilmArray Pneumonia testing of tracheal sample
Time frame: 48 hours from arrival of the respiratory sample at the laboratory
Turn Around Time administration of optimal antimicrobial treatment
Time frame: 1 week from arrival of the respiratory sample at the laboratory
Microbiological performances FA-PNEU test versus routine microbiology testing
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Other
Randomized Trial Measuring the Clinical Impact of the FilmArray® Pneumonia, a Prospective Interventional Trial
Acronym: FA-PNEU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07421440
Infections, Lung Diseases
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05334316
Infections, Lung Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT07070271
Infections, Lung Diseases
Giza, Egypt
View Trial Details